222 related articles for article (PubMed ID: 9872598)
1. Proteolysis of extracellular matrix by invadopodia facilitates human breast cancer cell invasion and is mediated by matrix metalloproteinases.
Kelly T; Yan Y; Osborne RL; Athota AB; Rozypal TL; Colclasure JC; Chu WS
Clin Exp Metastasis; 1998 Aug; 16(6):501-12. PubMed ID: 9872598
[TBL] [Abstract][Full Text] [Related]
2. Protease activity at invadopodial focal digestive areas is dependent on NHE1-driven acidic pHe.
Greco MR; Antelmi E; Busco G; Guerra L; Rubino R; Casavola V; Reshkin SJ; Cardone RA
Oncol Rep; 2014 Feb; 31(2):940-6. PubMed ID: 24337203
[TBL] [Abstract][Full Text] [Related]
3. Effect of matrix metalloproteinase inhibitor batimastat on breast cancer regrowth and metastasis in athymic mice.
Sledge GW; Qulali M; Goulet R; Bone EA; Fife R
J Natl Cancer Inst; 1995 Oct; 87(20):1546-50. PubMed ID: 7563189
[TBL] [Abstract][Full Text] [Related]
4. The alpha 3 beta 1 integrin is associated with mammary carcinoma cell metastasis, invasion, and gelatinase B (MMP-9) activity.
Morini M; Mottolese M; Ferrari N; Ghiorzo F; Buglioni S; Mortarini R; Noonan DM; Natali PG; Albini A
Int J Cancer; 2000 Aug; 87(3):336-42. PubMed ID: 10897037
[TBL] [Abstract][Full Text] [Related]
5. Human breast cancer cells activate procollagenase-1 and invade type I collagen: invasion is inhibited by all-trans retinoic acid.
Benbow U; Schoenermark MP; Orndorff KA; Givan AL; Brinckerhoff CE
Clin Exp Metastasis; 1999 May; 17(3):231-8. PubMed ID: 10432008
[TBL] [Abstract][Full Text] [Related]
6. Co-localization of cortactin and phosphotyrosine identifies active invadopodia in human breast cancer cells.
Bowden ET; Onikoyi E; Slack R; Myoui A; Yoneda T; Yamada KM; Mueller SC
Exp Cell Res; 2006 May; 312(8):1240-53. PubMed ID: 16442522
[TBL] [Abstract][Full Text] [Related]
7. Function of alpha3beta1-tetraspanin protein complexes in tumor cell invasion. Evidence for the role of the complexes in production of matrix metalloproteinase 2 (MMP-2).
Sugiura T; Berditchevski F
J Cell Biol; 1999 Sep; 146(6):1375-89. PubMed ID: 10491398
[TBL] [Abstract][Full Text] [Related]
8. Matrix metalloproteinase inhibitors.
Wojtowicz-Praga SM; Dickson RB; Hawkins MJ
Invest New Drugs; 1997; 15(1):61-75. PubMed ID: 9195290
[TBL] [Abstract][Full Text] [Related]
9. Matrix metalloproteinase inhibition prevents colon cancer peritoneal carcinomatosis development and prolongs survival in rats.
Aparicio T; Kermorgant S; Dessirier V; Lewin MJ; Lehy T
Carcinogenesis; 1999 Aug; 20(8):1445-51. PubMed ID: 10426790
[TBL] [Abstract][Full Text] [Related]
10. Diaphanous-related formins are required for invadopodia formation and invasion of breast tumor cells.
Lizárraga F; Poincloux R; Romao M; Montagnac G; Le Dez G; Bonne I; Rigaill G; Raposo G; Chavrier P
Cancer Res; 2009 Apr; 69(7):2792-800. PubMed ID: 19276357
[TBL] [Abstract][Full Text] [Related]
11. CRP2, a new invadopodia actin bundling factor critically promotes breast cancer cell invasion and metastasis.
Hoffmann C; Mao X; Dieterle M; Moreau F; Al Absi A; Steinmetz A; Oudin A; Berchem G; Janji B; Thomas C
Oncotarget; 2016 Mar; 7(12):13688-705. PubMed ID: 26883198
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of organ invasion by the matrix metalloproteinase inhibitor batimastat (BB-94) in two human colon carcinoma metastasis models.
Watson SA; Morris TM; Robinson G; Crimmin MJ; Brown PD; Hardcastle JD
Cancer Res; 1995 Aug; 55(16):3629-33. PubMed ID: 7627972
[TBL] [Abstract][Full Text] [Related]
13. CDCP1 regulates the function of MT1-MMP and invadopodia-mediated invasion of cancer cells.
Miyazawa Y; Uekita T; Ito Y; Seiki M; Yamaguchi H; Sakai R
Mol Cancer Res; 2013 Jun; 11(6):628-37. PubMed ID: 23439492
[TBL] [Abstract][Full Text] [Related]
14. Combined treatment with serine protease inhibitor aprotinin and matrix metalloproteinase inhibitor Batimastat (BB-94) does not prevent invasion of human esophageal and ovarian carcinoma cells in vivo.
Della Porta P; Soeltl R; Krell HW; Collins K; O'Donoghue M; Schmitt M; Krüger A
Anticancer Res; 1999; 19(5B):3809-16. PubMed ID: 10628317
[TBL] [Abstract][Full Text] [Related]
15. HDAC6 is required for invadopodia activity and invasion by breast tumor cells.
Rey M; Irondelle M; Waharte F; Lizarraga F; Chavrier P
Eur J Cell Biol; 2011; 90(2-3):128-35. PubMed ID: 20970878
[TBL] [Abstract][Full Text] [Related]
16. Phosphorylated cortactin recruits Vav2 guanine nucleotide exchange factor to activate Rac3 and promote invadopodial function in invasive breast cancer cells.
Rosenberg BJ; Gil-Henn H; Mader CC; Halo T; Yin T; Condeelis J; Machida K; Wu YI; Koleske AJ
Mol Biol Cell; 2017 May; 28(10):1347-1360. PubMed ID: 28356423
[TBL] [Abstract][Full Text] [Related]
17. Lipid rafts and caveolin-1 are required for invadopodia formation and extracellular matrix degradation by human breast cancer cells.
Yamaguchi H; Takeo Y; Yoshida S; Kouchi Z; Nakamura Y; Fukami K
Cancer Res; 2009 Nov; 69(22):8594-602. PubMed ID: 19887621
[TBL] [Abstract][Full Text] [Related]
18. Collagen induced MMP-2 activation in human breast cancer.
Thompson EW; Yu M; Bueno J; Jin L; Maiti SN; Palao-Marco FL; Pulyaeva H; Tamborlane JW; Tirgari R; Wapnir I
Breast Cancer Res Treat; 1994; 31(2-3):357-70. PubMed ID: 7881112
[TBL] [Abstract][Full Text] [Related]
19. Cancer cell-associated fibronectin induces release of matrix metalloproteinase-2 from normal fibroblasts.
Saad S; Gottlieb DJ; Bradstock KF; Overall CM; Bendall LJ
Cancer Res; 2002 Jan; 62(1):283-9. PubMed ID: 11782389
[TBL] [Abstract][Full Text] [Related]
20. Scaffold stiffness influences breast cancer cell invasion via EGFR-linked Mena upregulation and matrix remodeling.
Berger AJ; Renner CM; Hale I; Yang X; Ponik SM; Weisman PS; Masters KS; Kreeger PK
Matrix Biol; 2020 Jan; 85-86():80-93. PubMed ID: 31323325
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
